Lateral Flow Assays Market - Top Companies and Manufacturers

  • Report ID: 4871
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Companies Dominating the Lateral Flow Assays (LFA) Market

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Becton, Dickinson, and Company
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • F.Hoffmann-La Roche AG
    • QIAGEN N.V.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific, Inc.
    • Merck kGaA
    • PerkinElmer Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Abbott Laboratories announced the launch of a new lateral flow antigen test called the BinaxNOW COVID-19 Ag Card home test. This test is intended for non-prescription, and over-the-counter use, and provides results in 15 minutes. It is the first COVID-19 test authorized for non-prescription use by the US Reel and Drug Administration (FDA).
  •  Becton, Dickinson, and Company: SD announced the acquisition of a lateral now and clinical diagnostics company, Infiammatix. Inflammatix's technology enables rapid diagnosis and triage of patients with suspected infectious or inflammatory conditions. The acquisition is expected to enhance BD's diagnostic capabilities and expand its presence in the infectious disease market.

Author Credits:  Radhika Pawar


  • Report ID: 4871
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of lateral flow assays is estimated at USD 13.53 billion.

The lateral flow assays market size was valued at USD 12.76 billion in 2024 and is expected to cross USD 32.52 billion by the end of 2037, registering more than 7.4% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of infectious diseases and spiking healthcare spending will propel the market growth.

North America industry is assumed to hold a notable share of 26% by 2037, driving the development of new and innovative transverse flow analysis technologies in the region.

The major players in the market include Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Merck kGaA, PerkinElmer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample